HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1468853Generated: November 1, 2026
Methyl morpholine oxide → (1R,2R)-2-[1-(5-ethylpyrimidin-2-yl)piperidin-4-yl]cyclopropanecarbaldehyde
https://huagongshe.com/reaction/1468853
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Methyl morpholine oxide | HCID 82029 | — |
| Reactant | {(1R,2R)-2-[1-(5-ethylpyrimidin-2-yl)piperidin-4-yl]cyclopropyl}methanol | HCID 71136253 | — |
| Catalyst | HCID 178419074 | HCID 178419074 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | (1R,2R)-2-[1-(5-ethylpyrimidin-2-yl)piperidin-4-yl]cyclopropanecarbaldehyde | HCID 89297337 | — |
Reaction Steps
A mixture of the product of step A (5 g, 19.6 mmol), powdered 4 Å activated molecular sieves (10 g) and N-methylmorpholine oxide (3.5 g, 29.4 mmol) was stirred in DCM (100 mL) for 15 min at RT. Then the mixture was cooled to 0° C. and tetrapropylammonium perruthenate (0.69 g, 0.196 mmol) was added in one portion. The cold bath was removed and the mixture was stirred at RT for 1 h. The reaction was diluted with Et2O and stirred for 15 min at RT. The mixture was filtered through a plug of silica gel which was washed thoroughly with 2:1 hexane: ethyl acetate. The filtrate was concentrated to get a residue which was purified by column chromatography on silica (elution with 2:1 hexane:ethyl acetate) to yield the desired aldehyde. MS (ESI) m/z 260 [M+H]+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09006228B2 |
|---|
| Source dataset | uspto-grants-2015_04 |
|---|
| ORD ID | ord-76fb775e543b4018b16b28459f5e1642 |
|---|
| Source note | uspto-grants-2015_04 |
|---|